ECS
Director Trades
| Date | Director | Value |
|---|---|---|
| N. Schoerie | $9,000 |
Company News
ECS Botanics Achieves Positive Cash Flow Breakthrough in September Quarter
ECS Botanics Holdings (ASX: ECS) has delivered a positive net operating cash flow of $140,000 for the three months to end September, representing an improvement of $1.6 million on the June quarter and $900,000 on the same time last year. The company’s direct-to-consumer (B2C) strategy generated strong results to complement its established business-to-business (B2B) and export […]
ECS Botanics reports 50% increase in cannabis yields with new crop enclosure designs
Australian medicinal cannabis cultivator and manufacturer ECS Botanics (ASX: ECS) has reported a 50% increase in cannabis flower yields following the first harvest from its redesigned protective crop enclosures. The harvest produced 656 kilograms (wet weight) of flower compared to the previous high of 437kg of the same strain, also recording improvements in flower quality […]
ECS Botanics signs medicinal cannabis supply deal with MediCann Health
Victorian medicinal cannabis cultivator and manufacturer ECS Botanics (ASX: ECS) has secured a deal to supply $24 million of pharmaceutical-grade medicinal cannabis dried flower to Perth-based MediCann Health. The agreement will commence in January 2024 with over four tonnes of product to be delivered exclusively to MediCann over five years. It stipulates annual volumes of […]
Ongoing cannabis product demand drives more revenue growth for ECS Botanics
Medicinal cannabis and hemp company ECS Botanics (ASX: ECS) has announced it is on track to deliver another consecutive quarter of revenue growth thanks to sales of its dried flower and cannabis oil products. The company expects to report revenue of about $2 million for the quarter due to end 31 March, which would represent […]
ECS Botanics makes first shipment of dried cannabis flower to UK
Medicinal cannabis and hemp company ECS Botanics Holdings (ASX: ECS) has announced the successful completion of its first shipment of dried cannabis flower to Lyphe Group in the United Kingdom. The shipment marks the first international export of the company’s Australian grown product. Lyphe Group is the largest distributor of medicinal cannabis in the UK […]
ECS Botanics welcomes another record quarter driven by demand for cannabis products
Medicinal cannabis and hemp producer ECS Botanics (ASX: ECS) has welcomed another consecutive record quarter for the three months ending December 2021 (Q2 FY2022). The company achieved $1.4 million in revenue, which was 58% higher than Q1 FY2022 and up a whopping 308% on the previous corresponding period. Driving the ongoing growth was strong demand […]
ECS Botanics achieves another record quarter
Medicinal cannabis and hemp company ECS Botanics (ASX: ECS) has announced another consecutive quarter of record revenue growth, driven by strong volumes from new and existing domestic customers. The Australian company today reported a revenue of approximately $1.5 million for the December quarter, up 65% on September and 325% higher than the three months ended […]
ECS Botanics signs landmark medicinal cannabis resin supply deal with Cannvalate
Vertically-integrated medicinal cannabis and industrial hemp business ECS Botanics (ASX: ECS) has secured a landmark deal to supply resin to Australian cannabis company Cannvalate. The deal will be managed through subsidiary ECS Botanics MC Pty Ltd and will allow for the supply of medicinal cannabis resin starting within the next 12 months. Supply will continue for three […]
ECS Botanics inks cannabis supply and tolling deal with Sun Pharma
Medicinal cannabis and hemp company ECS Botanics Holdings (ASX: ECS) has revealed it has entered into a collaborative supply and toll processing agreement for cannabis biomass extraction with pharmaceutical company Sun Pharma. Sun Pharma is an Australia-based subsidiary of Sun Pharmaceutical Industries, the fourth largest specialty generic pharmaceutical company in the world. With global revenues in excess […]
ECS Botanics raises $6.6m to accelerate growth after record September quarter
Following a record September quarter, medicinal cannabis and hemp company ECS Botanics (ASX: ECS) has received firm commitments to raise $6.6 million to accelerate its growth. ECS Botanics says the $6.6 million placement was heavily supported, with investors scooping up 200 million new shares at $0.033 each. The issue price of $0.033 was a 15.38% […]
Company Videos
No videos found.